Bcl-2 Inhibits Chemotherapy-induced Apoptosis in Neuroblastoma

Cancer Research

Volumn 54, Issue 12, 1994, Pages 3253-3259

  Merchant, Audrea K ^b   Maybaum, Jonathan ^b   Rode, Christopher K ^a   Bloch, Craig A ^a   Castle, Valerie P ^a  

^a Department of Pathology ^*  (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DNA; ETOPOSIDE; ONCOPROTEIN;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DENSITOMETRY; DIAGNOSIS; DNA CONTENT; DNA DEGRADATION; DOSE RESPONSE; DRUG RESISTANCE; ETIOLOGY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NEUROBLASTOMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; PULSED FIELD GEL ELECTROPHORESIS; SPECTROPHOTOMETRY; TUMOR RESISTANCE;

APOPTOSIS; CELL DIVISION; CELL SURVIVAL; CISPLATIN; DNA, NEOPLASM; DRUG RESISTANCE; ETOPOSIDE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0028322065     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C.M. Involvement of the bcl-2 oncogene in human follicular lymphoma. Science (Washington DC), 228: 1440-1443, 1985.
2. Tsujimoto, Y., and Croce, C.M. Analysis of the structure, transcripts and protein products of bcl-2 the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83: 5214-5218, 1986.
3. Hockenbery, D.M., Zutter, M., Hickey, W., Nahm, M., and Korsmeyer, S.J. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA, 88: 6961-6965, 1991.
4. Hockenbery, D.M., Nuñez, G., Milliman, C., Schreiber, R.D., and Korsmeyer, S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334-336, 1990.
5. Jacobson, M.D., Burne, J.F., King, M.P., Miyashita, T., Reed, J.C., and Raff, M.C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature (Lond.), 361: 365-369, 1993.
6. Liu, Y.J., Mason, D.Y., Johnson, G.D., Abbot, S., Gregory, C.D., Hardie, C.D., Hardie, D.L., Gordon, J., and MacLennan, I.C.M. Germinal center cells express Bcl-2 protein after activation by signals which prevent their entry to apoptosis. Eur. J. Immunol., 21: 1905-1910, 1991.
7. Nuñez, G., London, L., Hockenbery, D., Alexander, M., McKearn, J.P., and Korsemeyer, S.J. Deregulated bcl-2 gene expression selectively prolongs the survival of growth factor-deprived hematopoietic cell lines. J. Immunol., 144: 3602-3610.
8. Vaux, D.L., Cory, S., and Adams, J.M. Bcl-2 promotes the survival of hematopoietic cells and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335: 440-442, 1988.
9. Tsujimoto, Y. Stress-resistance conferred by high level of Bcl-2 protein in human B-lymphoblastoid cell line. Oncogene, 4: 1331-1336, 1989.
10. Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanagawa, O., and Korsmeyer, S.J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67: 879-888, 1991.
11. McDonnell, T.J., Deane, N., Platt, F.M., Nuñez, G., Jaeger, V., McKearn, J.P., and Korsemeyer, S.J. bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57: 79-88, 1989.
12. Abe-Dohmae, K.S., Harada, N., Yamada, K., and Tanaka, R. bcl-2 gene is highly expressed during neurogenesis in the central nervous system. Biochem. Biophys. Res. Commun., 191: 915-921, 1993.
13. Garcia, I., Marinou, I., Tsujimoto, Y., and Martinou, J.C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science (Washington DC), 258: 302-304, 1992.
14. Batistatou, A., and Greene, L.A. 1-Aurintricarboxylic acid rescues PC-12 cells and sympathetic neurons from cell death by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J. Cell Biol., 115: 461-471, 1991.
15. Allsopp, T.E., Wyatt, S., Paterson, H.F., and Davies, A.M. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell, 73: 295-307, 1993.
16. Reed, J.C., Meister, L.M., Tanaka, S., Cuddy, M., Yum, S., Geyer, C., and Pleasure, D. Differential expression of bcl-2 protooncogene in neuroblastoma and other tumor cell lines of neural origin. Cancer Res., 51: 6529-6538, 1991.
17. Castle, V.P., Heidelberger, K.P., Bromberg, J., Ou, X., Dole, M., and Nunez, G. Expression of the apoptosis-suppressing protein Bcl-2 in neuroblastoma is associated with poor stage disease, unfavorable histology and N-myc amplification. Am. J. Pathol., 143: 1543-1550, 1993.
18. Barry, M.A., Behnke, C.A., and Eastman, A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol., 40: 2353-2362, 1990.
19. Dive, C., and Wyllie, A.H. Apoptosis and cancer chemotherapy. In: J.A. Hickman and T.R. Tritton (eds.), Cancer Chemotherapy, pp. 21-56. Oxford, United Kingdom: Blackwell Publications, 1993.
20. Miyashita, T., and Reed, J.C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151-157, 1993.
21. Alnemri, E.S., Fernandes, T.F., Haldar, S., Croce, C.M., and Litwack, G. Involvement of Bcl-2 in glucocorticoid induced apoptosis of human pre-B-leukemias. Cancer Res., 52: 491-495, 1992.
22. Kamesaki, S. Kamesaki, H., Jorgensen, T.J., Tanizawa, A., Pommier, Y., and Cossman, J. Bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase-II induced DNA strand breaks and their repair. Cancer Res., 53: 4251-4256, 1993.
23. Walton, M.I., Whysong, D., O'Connor, P.M., Hockenbery, D., Korsmeyer, S.J., and Kohn, K.W. Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res., 53: 1853-1861, 1993.
24. Collins, M.F.L., Marvel, J., Malde, P., and Lopez-Rivas, A. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J. Exp. Med., 176: 1043-1051, 1992.
25. Oliver, F.J., Marvel, J., Colins, M.K., and Lopez-Rivas, A. bcl-2 oncogene protects a bone-marrow derived pre-B cell line from 5 ‘ -fluoro-2 ‘deoxyuridine-induced apoptosis. Biochem. Biophy. Res. Commun., 194: 126-132, 1993.
26. Fuhlbrigge, R.C., Fine, S.M., Unanue, E.R., and Chaplin, D.D. Expression of membrane interleukin 1 by fibrolasts transfected with murine pro-leukin 1 alpha cDNA. Proc. Natl. Acad. Sci. USA, 85: 5649-5653, 1988.
27. Biedler, J.L., Helson, L., and Spengler, B.A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res., 33: 2643-2652, 1973.
28. Feigner, P.L., Gadek, T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P., Ringold, G.M., and Danielsen, M. Lipofection: a highly efficient lipid-mediated DNA transfection procedure. Proc. Natl. Acad. Sci. USA, 84: 74137416, 1987.
29. Castle, V.P., Ou, X., O'Rourke, K., and Dixit, V.M. High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers serum and anchorage-independent growth. J. Biol. Chem., 268(4): 2899-2903, 1993.
30. Hansen, M.B., Nielsen, S.E., and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth and cell kill. J. Immunol. Methods, 119: 203-210, 1989.
31. Nicoletti, I., Migliorati, G., Pagliacci, M.G., Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide and flow cytometry. J. Immunol. Methods, 139: 271-279, 1991.
32. Finney, M. Preparation and analysis of DNA. In: F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl (eds.), Current Protocols in Molecular Biology, Vol. 1, pp. 2.5.11-2.5.15. New York: Wiley/Interscience, 1989.
33. Canman, C.E., Tang, H., Normolle, D.P., Lawrence, T.S., and Maybaum, J. Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity. Proc. Natl. Acad. Sci. USA, 98: 10474-10478, 1992.
34. Darzynkiewicz, Z., Bruno, S., Del-Bino, G., Gorcyzyca, W., Hotz, M.A., Lassota, P., and Traganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry, 13: 795-808, 1992.
35. Oberhammer, F., Wilson, J.W., Dive, C., Morris, I.D., Hickman, J.A., Wakeling, A.E., Walker, P.R., and Sikorska, M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J., 12: 3679-3684, 1993.
36. Miyashita, T., and Reed, J.C. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res., 52: 5407-5411, 1992.
37. Hanada, M., Krajewski, S., Tanada, S., Cazals-Hatem, D., Spengler, B.A., Ross, R.A., Biedler, J.L., and Reed, J.C. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res., 53: 4978-4986, 1993.
38. Filipski, J., Leblanc, J., Youdale, T., Sikorska, M., and Walker, P.R. Periodicity of DNA folding in higher order chromatin structures. EMBO J., 9: 1319-1327, 1990.
39. Gasser, S.M., Amati, B.B., Cardenas, M.E., and Hofman, J.F. Studies on scaffold attachment sites and their relation to genome function. Int. Rev. Cytol., 119: 57-96, 1989.
40. Kohn, K.W., Pommier, Y., Kerrigan, D., Markovits, J., and Covey, J.M. Topoisomerase II as a target of anti-cancer drug action in mammalian cells. Natl. Cancer Inst. Monogr., 4: 61-71, 1987.
41. Fisher, T.C., Milner, A.E., Gregory, C.D., Jackman, A.L., Aherne, G.W., Hartley, J.A., Dive, C., and Hickman, J.A. Bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res., 53: 3321-3326, 1993.
42. Hockenbery, D.M., Oltval, N.Z., Xiao-Ming, Y., Milliman, C.L., and Korsmeyer, S.J. Bcl-2 functions in an anti-oxidant pathway to prevent apoptosis. Cell, 75: 241-251, 1993.
43. Kane, D.J., Sarafian, T.A., Anton, R., Hahn, H., Gralla, E.B., Selverstone, J., Valentine, J.S., örd, T., and Bredesen, D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science (Washington DC), 262: 1274-1277, 1993.
44. Hannemann, J., and Baumann, K. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicology, 51: 119-132, 1988.
45. Sugihara, K., and Gemba, M. Modification of cisplatin toxicity by antioxidants. Jpn. J. Pharmacol., 40: 353-355, 1986.
46. Mans, D.R., Retèl, J., Van Maanen, J.M.S., Lafleur, M.V.M., van Schaik, M.A., Pinedo, H.M., and Lankelma, J. Role of the semi-quinone free radical of the anti-tumor agent etoposide (VP-16-213) in the inactivation of single-and doublestranded ФX174 DNA. Br. J. Cancer, 62: 54-60, 1990.
47. Mans, D.R.A., Lafleur, M.V.M., Westmijze, E.J., Horn, I.R., Bets, D., Schuurhuis, G.J., Lankelma, J., and Retèl J. Reactions of glutathione with the catechol, the ortho-quinone and the semi-quionone free radical of etoposide: consequences for DNA inactivation. Biochem. Pharmacol., 43: 1761-1768, 1992.